Skip to main content

Articles

Page 6 of 87

  1. Airway tuft cells, formerly called brush cells have long been described only morphologically in human airways. More recent RNAseq studies described a chemosensory cell population, which includes tuft cells, by...

    Authors: Monika I. Hollenhorst, Thomas Husnik, Malin Zylka, Nele Duda, Veit Flockerzi, Thomas Tschernig, Stephan Maxeiner and Gabriela Krasteva-Christ
    Citation: Respiratory Research 2023 24:267
  2. Authors: Nazli Khodayari, Regina Oshins, Borna Mehrad, Jorge E Lascano, Xiao Qiang, Jesse R West, L Shannon Holliday, Jungnam Lee, Gayle Wiesemann, Soroush Eydgahi and Mark Brantly
    Citation: Respiratory Research 2023 24:266

    The original article was published in Respiratory Research 2022 23:232

  3. Quantitative interstitial abnormalities (QIA) are an automated computed tomography (CT) finding of early parenchymal lung disease, associated with worse lung function, reduced exercise capacity, increased resp...

    Authors: Bina Choi, Raúl San José Estépar, Suneeta Godbole, Jeffrey L. Curtis, Jennifer M. Wang, Rubén San José Estépar, Ivan O. Rosas, Jared R. Mayers, Brian D. Hobbs, Craig P. Hersh, Samuel Y. Ash, MeiLan K. Han, Russell P. Bowler, Kathleen A. Stringer, George R. Washko and Wassim W. Labaki
    Citation: Respiratory Research 2023 24:265
  4. The prevalence and clinical correlates of antibiotic resistance genes (ARGs) in bronchiectasis are not entirely clear. We aimed to profile the ARGs in sputum from adults with bronchiectasis, and explore the as...

    Authors: Xin-zhu Yi, Jun-hao Yang, Yan Huang, Xiao-rong Han, Hui-min Li, Lai-jian Cen, Zhen-hong Lin, Cui-xia Pan, Zhang Wang and Wei-jie Guan
    Citation: Respiratory Research 2023 24:264
  5. Pulmonary arterial hypertension (PAH), Group 1 pulmonary hypertension (PH), is a type of pulmonary vascular disease characterized by abnormal contraction and remodeling of the pulmonary arterioles, manifested ...

    Authors: Cheng Zeng, Jing Liu, Xialei Zheng, Xinqun Hu and Yuhu He
    Citation: Respiratory Research 2023 24:263
  6. The standard therapy for bronchial asthma consists of combinations of acute (short-acting ß2-sympathomimetics) and, depending on the severity of disease, additional long-term treatment (including inhaled glucocor...

    Authors: Paulina Hempel, Virag Klein, Anna Michely, Svenja Böll, Annette D. Rieg, Jan Spillner, Till Braunschweig, Saskia von Stillfried, Norbert Wagner, Christian Martin, Klaus Tenbrock and Eva Verjans
    Citation: Respiratory Research 2023 24:262
  7. Due to the relatively short existence of alternative tobacco products, gaps exist in our current understanding of their long-term respiratory health effects. We therefore undertook the first-ever side-by-side ...

    Authors: Tariq A. Bhat, Suresh G. Kalathil, Noel Leigh, Alan Hutson, Maciej L. Goniewicz and Yasmin M. Thanavala
    Citation: Respiratory Research 2023 24:261
  8. Severe asthma is associated with substantial mortality and has unmet therapeutic need. A subset of severe asthma is characterized by neutrophilic airway inflammation. Classically activated (or M1) macrophages ...

    Authors: Chenli Chang, Gongqi Chen, Wenliang Wu, Dian Chen, Shengchong Chen, Jiali Gao, Yuchen Feng and Guohua Zhen
    Citation: Respiratory Research 2023 24:260
  9. The diaphragm function assessed by ultrasound has been well-studied in COPD, asthma, and intensive care. However, there are only a few studies on diffuse interstitial lung disease, while dyspnea and quality of...

    Authors: Jules Milesi, Alain Boussuges, Paul Habert, Julien Bermudez, Martine Reynaud-Gaubert, Stéphane Delliaux, Fabienne Bregeon and Benjamin Coiffard
    Citation: Respiratory Research 2023 24:259
  10. Mechanical thrombectomy has been shown to reduce thrombus burden and pulmonary artery pressure (PAP) and to improve right ventricular (RV) function in patients with high-risk or intermediate-high-risk pulmonar...

    Authors: Lucas Lauder, Patricia Pérez Navarro, Felix Götzinger, Sebastian Ewen, Hussam Al Ghorani, Bernhard Haring, Philipp M. Lepper, Saarraaken Kulenthiran, Michael Böhm, Andreas Link, Bruno Scheller and Felix Mahfoud
    Citation: Respiratory Research 2023 24:257
  11. Neutrophilic airway inflammation is a challenge in asthma management and is associated with poor patient prognosis. Mucin 1 (MUC1), which contains a cytoplasmic tail (MUC1-CT), has been found to mediate glucoc...

    Authors: Lu Liu, Ling Zhou, Lingling Wang, Zhenyu Mao, Pengdou Zheng, Fengqin Zhang, Huojun Zhang and Huiguo Liu
    Citation: Respiratory Research 2023 24:255
  12. Fibroblast activation protein-α (FAPα) is a marker of activated fibroblasts that can be selectively targeted by an inhibitor (FAPI) and visualised by PET/CT imaging. We evaluated whether the measurement of FAP...

    Authors: Philomène Lavis, Julien Pingitore, Gilles Doumont, Ani Garabet, Gaetan Van Simaeys, Simon Lacroix, Nicolas Passon, Christophe Van Heymbeek, Coraline De Maeseneire, Justine Allard, Amandine Collin, François Huaux, Christine Decaestecker, Isabelle Salmon, Serge Goldman, Alessandra Kupper Cardozo…
    Citation: Respiratory Research 2023 24:254
  13. CD147 is an important glycoprotein that participates in the progression of diverse cancers. This study aims to explore the specific function of CD147 in lung adenocarcinoma (LUAD) and to reveal related downstr...

    Authors: Ning Zhang, Zhouzhong Liu, Xuwang Lai, Shubin Liu and Yuli Wang
    Citation: Respiratory Research 2023 24:253

    The Correction to this article has been published in Respiratory Research 2024 25:136

  14. Emerging evidence indicates that circular RNAs (circRNAs) play vital roles in tumor progression, including lung adenocarcinomas (LUAD). However, the mechanisms by which circRNAs promote the progression of LUAD...

    Authors: Haoran Li, Haifa Guo, Qi Huang, Shaodong Wang, Xiao Li and Mantang Qiu
    Citation: Respiratory Research 2023 24:252
  15. Interstitial lung diseases (ILDs) are complex and heterogeneous diseases. The use of traditional diagnostic classification in ILD can lead to suboptimal management, which is worsened by not considering the mol...

    Authors: Francesco Amati, Paolo Spagnolo, Christopher J. Ryerson, Justin M. Oldham, Andrea Gramegna, Anna Stainer, Marco Mantero, Nicola Sverzellati, Donato Lacedonia, Luca Richeldi, Francesco Blasi and Stefano Aliberti
    Citation: Respiratory Research 2023 24:251
  16. Deep inspiration (DI) has been shown to induce bronchodilation and bronchoprotection in bronchochallenged healthy subjects, but not in asthmatics. Strain-induced relaxation of airway smooth muscle (ASM) is con...

    Authors: Yuto Yasuda, Lu Wang, Pasquale Chitano and Chun Y. Seow
    Citation: Respiratory Research 2023 24:250
  17. Platelet count (PLT) is associated positively with lung cancer risk but has a more complex association with body mass index (BMI), positive only in women (mainly never smokers) and inverse in men (mainly ever ...

    Authors: Sofia Christakoudi, Konstantinos K. Tsilidis, Evangelos Evangelou and Elio Riboli
    Citation: Respiratory Research 2023 24:249
  18. Microbiome dysbiosis can have long-lasting effects on our health and induce the development of various diseases. Bronchopulmonary dysplasia (BPD) is a multifactorial disease with pre- and postnatal origins inc...

    Authors: Birte Staude, Silvia Gschwendtner, Tina Frodermann, Frank Oehmke, Thomas Kohl, Susanne Kublik, Michael Schloter and Harald Ehrhardt
    Citation: Respiratory Research 2023 24:248
  19. The dysregulation of local circadian clock has been implicated in the pathogenesis of a broad spectrum of diseases. However, the pathophysiological role of intrinsic circadian clocks Rev-Erbα in ischemia-reper...

    Authors: Shi-Jye Chu, Wen-I Liao, Hsin-Ping Pao, Shu-Yu Wu and Shih-En Tang
    Citation: Respiratory Research 2023 24:247
  20. Although COVID-19 vaccines and their booster regimens protect against symptomatic infections and severe outcomes, there is limited evidence about their protection against asymptomatic and symptomatic infection...

    Authors: Ting Zeng, Yaoqin Lu, Yanji Zhao, Zihao Guo, Shengzhi Sun, Zhidong Teng, Maozai Tian, Jun Wang, Shulin Li, Xucheng Fan, Weiming Wang, Yongli Cai, Gengze Liao, Xiao Liang, Daihai He, Kai Wang…
    Citation: Respiratory Research 2023 24:246
  21. Interstitial lung abnormalities (ILA) often represent early fibrotic changes that can portend a progressive fibrotic phenotype. In particular, the fibrotic subtype of ILA is associated with increased mortality...

    Authors: Aravind A. Menon, Minyi Lee, Xu Ke, Rachel K. Putman, Takuya Hino, Jonathan A. Rose, Fenghai Duan, Samuel Y. Ash, Michael H. Cho, George T. O’Connor, Josée Dupuis, Hiroto Hatabu, Marc E. Lenburg, Ehab S. Billatos and Gary M. Hunninghake
    Citation: Respiratory Research 2023 24:245
  22. This study, in patients with symptomatic chronic obstructive pulmonary disease (COPD), explored switching therapy from non-extrafine high-dose inhaled corticosteroid/long-acting β2-agonist (ICS/LABA; fluticasone ...

    Authors: Gwen S. Skloot, Alessandro Guasconi, Benjamin R. Lavon, George Georges, Wilfried De Backer, Dmitry Galkin, Mauro Cortellini, Ilaria Panni and Jason H. T. Bates
    Citation: Respiratory Research 2023 24:244
  23. Chronic obstructive pulmonary disease (COPD) is a lung disease characterised by airflow-limiting inflammation and mucus production. Acute exacerbations are a major cause of COPD-related morbidity and mortality...

    Authors: Cecilia Brettoni, Alessandro Muzzi, Simona Rondini, Vincent Weynants and Silvia Rossi Paccani
    Citation: Respiratory Research 2023 24:243
  24. The pulmonary extracellular matrix (ECM) is a macromolecular structure that provides mechanical support, stability and elastic recoil for different pulmonary cells including the lung fibroblasts. The ECM plays...

    Authors: Sakshi Phogat, Fama Thiam, Safiya Al Yazeedi, Filsan Ahmed Abokor and Emmanuel Twumasi Osei
    Citation: Respiratory Research 2023 24:242
  25. Computed tomography (CT) imaging and artificial intelligence (AI)-based analyses have aided in the diagnosis and prediction of the severity of COVID-19. However, the potential of AI-based CT quantification of ...

    Authors: Hiromu Tanaka, Tomoki Maetani, Shotaro Chubachi, Naoya Tanabe, Yusuke Shiraishi, Takanori Asakura, Ho Namkoong, Takashi Shimada, Shuhei Azekawa, Shiro Otake, Kensuke Nakagawara, Takahiro Fukushima, Mayuko Watase, Hideki Terai, Mamoru Sasaki, Soichiro Ueda…
    Citation: Respiratory Research 2023 24:241
  26. Idiopathic pulmonary fibrosis (IPF) has an unknown aetiology and limited treatment options. A recent meta-analysis identified three novel causal variants in the TERT, SPDL1, and KIF15 genes. This observational st...

    Authors: Maria Hollmén, Atte Laaka, Juulia J. Partanen, Jukka Koskela, Eva Sutinen, Riitta Kaarteenaho, Mari Ainola and Marjukka Myllärniemi
    Citation: Respiratory Research 2023 24:240
  27. Use of combinations of long-acting β2 agonists/long-acting muscarinic antagonists (LABA/LAMA) in patients with chronic obstructive pulmonary disease (COPD) is increasing. Nevertheless, existing evidence on cardio...

    Authors: Chun-Yu Chen, Sheng-Wei Pan, Chia-Chen Hsu, Jason J. Liu, Hiraku Kumamaru and Yaa-Hui Dong
    Citation: Respiratory Research 2023 24:239
  28. Rhinovirus infections commonly evoke asthma exacerbations in children and adults. Recurrent asthma exacerbations are associated with injury-repair responses in the airways that collectively contribute to airwa...

    Authors: Cassandra Spector, Camden M. De Sanctis, Reynold A. Panettieri Jr. and Cynthia J. Koziol-White
    Citation: Respiratory Research 2023 24:238
  29. Airway basal stem cells (ABSCs) have self-renewal and differentiation abilities. Although an abnormal mechanical environment related to chronic airway disease (CAD) can cause ABSC dysfunction, it remains uncle...

    Authors: Li-Qin Lin, Hai-Kang Zeng, Yu-Long Luo, Di-Fei Chen, Xiao-Qian Ma, Huan-Jie Chen, Xin-Yu Song, Hong-Kai Wu and Shi-Yue Li
    Citation: Respiratory Research 2023 24:237
  30. The role of the immune system in the pathobiology of Idiopathic Pulmonary Fibrosis (IPF) is controversial.

    Authors: Tamara Cruz, Núria Mendoza, Sandra Casas-Recasens, Guillaume Noell, Fernanda Hernandez-Gonzalez, Alejandro Frino-Garcia, Xavi Alsina-Restoy, María Molina, Mauricio Rojas, Alvar Agustí, Jacobo Sellares and Rosa Faner
    Citation: Respiratory Research 2023 24:236
  31. The ORBE II study aimed to describe the characteristics and clinical outcomes of adult patients with severe eosinophilic asthma (SEA) treated with benralizumab in a real-world setting in Spain.

    Authors: Alicia Padilla-Galo, Isabel Moya Carmona, Pilar Ausín, Luis Carazo Fernández, Ismael García-Moguel, José Luis Velasco-Garrido, Rubén Andújar-Espinosa, Francisco Casas-Maldonado, Eva Martínez-Moragón, Carlos Martínez Rivera, Elisabet Vera Solsona, Fernando Sánchez-Toril López, Andrea Trisán Alonso, Marina Blanco Aparicio, Marcela Valverde-Monge, Borja Valencia Azcona…
    Citation: Respiratory Research 2023 24:235
  32. As the prevalence of OSA increases in older patients, the proportion of elderly patients treated with CPAP is expected to become even higher. We studied CPAP-adherence in a real-life cohort involving a large p...

    Authors: Arnaud Prigent, Clément Blanloeil, Anne-Laure Serandour, Franck Barlet, Frédéric Gagnadoux and Dany Jaffuel
    Citation: Respiratory Research 2023 24:234
  33. Bone marrow mesenchymal stem cell-derived extracellular vesicles (BMSC-EVs) have been highly studied with their critical roles as carriers of therapeutic targets such as microRNAs (miRNAs) in the treatment of ...

    Authors: Mengzhi Wan, Caiju Lu, Yu Liu, Feng Luo, Jing Zhou and Fei Xu
    Citation: Respiratory Research 2023 24:233
  34. The clinical significance of Stenotrophomonas maltophilia in patients with COPD is poorly understood. We aimed to determine whether a lower respiratory tract culture positive for S. maltophilia in COPD patients w...

    Authors: Christian Rønn, Peter Kamstrup, Josefin Eklöf, Louise Lindhardt Toennesen, Jonas Bredtoft Boel, Christian Ostergaard Andersen, Ram Benny Dessau, Jon Torgny Wilcke, Pradeesh Sivapalan, Charlotte Suppli Ulrik and Jens-Ulrik Stæhr Jensen
    Citation: Respiratory Research 2023 24:232
  35. Asthma is a common, chronic inflammatory disease of the airways that affects millions of people worldwide and is associated with significant healthcare costs. Eosinophils, a type of immune cell, play a critica...

    Authors: Kunlu Shen, Mengyuan Zhang, Ruiheng Zhao, Yun Li, Chunxiao Li, Xin Hou, Bingqing Sun, Bowen Liu, Min Xiang and Jiangtao Lin
    Citation: Respiratory Research 2023 24:231
  36. Venovenous extracorporeal membrane oxygenation (vvECMO) is used to treat hypoxia in patients with severe acute respiratory distress syndrome (ARDS). Nevertheless, uncertainty exists regarding the optimal timin...

    Authors: Peter Rosenberger, Lisa Korell, Helene A. Haeberle, Valbona Mirakaj, Alice Bernard, Linyan Tang, Andreas Körner, Peter Martus and Michael Koeppen
    Citation: Respiratory Research 2023 24:230
  37. Triple therapy is recommended for patients with chronic obstructive pulmonary disease (COPD) who remain symptomatic despite dual therapy. The optimal timing of triple therapy following an exacerbation of COPD ...

    Authors: Afisi S. Ismaila, Kieran J. Rothnie, Robert P. Wood, Victoria L. Banks, Lucinda J. Camidge, Alexandrosz Czira, Chris Compton, Raj Sharma, Shannon N. Millard, Olivia Massey and David M. G. Halpin
    Citation: Respiratory Research 2023 24:229

    The Correction to this article has been published in Respiratory Research 2024 25:152

  38. Authors: Stefania Lo Cicero, Germana Castelli, Giovanna Blaconà, Sabina Maria Bruno, Giovanni Sette, Riccardo Pigliucci, Valeria Rachela Villella, Speranza Esposito, Immacolata Zollo, Francesca Spadaro, Ruggero De Maria, Mauro Biffoni, Giuseppe Cimino, Felice Amato, Marco Lucarelli and Adriana Eramo
    Citation: Respiratory Research 2023 24:228

    The original article was published in Respiratory Research 2023 24:217

  39. Functional alveolar regeneration is essential for the restoration of normal lung homeostasis after acute lung injury (ALI) and acute respiratory distress syndrome (ARDS). Lung is a relatively quiescent organ a...

    Authors: Jianhui Sun, Huacai Zhang, Di Liu, Wenyi Liu, Juan Du, Dalin Wen, Luoxi Li, Anqiang Zhang, Jianxin Jiang and Ling Zeng
    Citation: Respiratory Research 2023 24:227
  40. Small airways disease plays a key role in the pathogenesis of chronic obstructive pulmonary disease (COPD) and is a major cause of obstruction; therefore, it is a critical pharmacotherapy target. This study ev...

    Authors: Omar Usmani, Grace Li, Jan De Backer, Hosein Sadafi, Libo Wu and Jonathan Marshall
    Citation: Respiratory Research 2023 24:226
  41. Sensitization to Staphylococcus aureus enterotoxins A (SEA) and B (SEB) has been associated with asthma severity, exacerbations, and disease control. Our study aimed to investigate if there are differences in ...

    Authors: Meropi Karakioulaki, Caroline Maria Berkemeier, Ingmar Heijnen, Leticia Grize, Eleni Papakonstantinou, Antonis Goulas, Michael Tamm and Daiana Stolz
    Citation: Respiratory Research 2023 24:225
  42. Muscle loss is prevalent in chronic obstructive pulmonary disease (COPD). Prior studies evaluating musculoskeletal dysfunction in COPD have focused on individuals with baseline low muscle mass. Currently, ther...

    Authors: Richard H. Zou, S. Mehdi Nouraie, Chad Karoleski, Yingze Zhang, Frank C. Sciurba, Daniel E. Forman and Jessica Bon
    Citation: Respiratory Research 2023 24:224
  43. Achieving and maintaining a low-risk profile is associated with favorable outcome in pulmonary arterial hypertension (PAH). The effects of treatment on risk profile are variable among patients.

    Authors: Agustin R. Garcia, Isabel Blanco, Lluis Ramon, Jesús Pérez-Sagredo, Francisco J. Guerra-Ramos, Clara Martín-Ontiyuelo, Olga Tura-Ceide, Francisco Pastor-Pérez, Pilar Escribano-Subías and Joan A. Barberà
    Citation: Respiratory Research 2023 24:223
  44. Idiopathic pulmonary fibrosis (IPF) bears high mortality due to unclear pathogenesis and limited therapeutic options. Therefore, identifying novel regulators is required to develop alternative therapeutic stra...

    Authors: Mingting Wu, Zhenyan Wang, Xiaoqian Shi, Danni Zan, Hong Chen, Shuqiao Yang, Fangping Ding, Liu Yang, Pingping Tan, Runlin Z. Ma, Jing Wang, Lishuang Ma, Yingmin Ma and Jiawei Jin
    Citation: Respiratory Research 2023 24:222
  45. Although asthma and chronic obstructive pulmonary disease (COPD) are two distinct chronic airway inflammatory diseases, they often co-exist in a patient and the condition is referred to as asthma-COPD overlap ...

    Authors: Surajit Dey, Wenying Lu, Greg Haug, Collin Chia, Josie Larby, Heinrich C. Weber, Archana Vijay Gaikwad, Prem Bhattarai, Affan Mahmood Shahzad, Prabuddha S. Pathinayake, Peter A. B. Wark, Mathew Suji Eapen and Sukhwinder Singh Sohal
    Citation: Respiratory Research 2023 24:221
  46. Pulmonary arterial hypertension is a major cause of death in systemic lupus erythematosus, but there are no tools specialized for predicting survival in systemic lupus erythematosus-associated pulmonary arteri...

    Authors: Jingge Qu, Mengtao Li, Xiao Zhang, Miaojia Zhang, Xiaoxia Zuo, Ping Zhu, Shuang Ye, Wei Zhang, Yi Zheng, Wufang Qi, Yang Li, Zhuoli Zhang, Feng Ding, Jieruo Gu, Yi Liu, Junyan Qian…
    Citation: Respiratory Research 2023 24:220
  47. Serum biomarkers in the evaluation of organ involvement and prognostic monitoring of sarcoidosis have not been determined. The purpose of this study was to identify common biomarkers that could be used to asse...

    Authors: Ying Zhou, Xianqiu Chen, Mengmeng Zhao, Elyse E. Lower and Robert P. Baughman
    Citation: Respiratory Research 2023 24:219
  48. Environmental co-exposure to allergen and traffic-related air pollution is common globally and contributes to the exacerbation of respiratory diseases. Individual responses to environmental insults remain vari...

    Authors: Andrew Robinson, Ryan D. Huff, Min Hyung Ryu and Chris Carlsten
    Citation: Respiratory Research 2023 24:218

Annual Journal Metrics

  • 2022 Citation Impact
    5.8 - 2-year Impact Factor
    5.9 - 5-year Impact Factor
    1.444 - SNIP (Source Normalized Impact per Paper)
    1.753 - SJR (SCImago Journal Rank)

    2023 Speed
    8 days submission to first editorial decision for all manuscripts (Median)
    105 days submission to accept (Median)

    2023 Usage 
    2,949,876 downloads
    2,397 Altmetric mentions